Vivo Capital, LLC Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$995.9B
Holdings
49
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRMYHarmony Biosciences Holdings Inc | 4,093,785 | $199.7B | 20.05% | |
| 2 | —Sierra Oncology, Inc | 3,329,509 | $183.1B | 18.38% | |
| 3 | TILInstil Bio Inc | 12,486,787 | $57.7B | 5.79% | |
| 4 | OPHTEURIveric Bio Inc | 5,238,634 | $50.4B | 5.06% | |
| 5 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 3.83% | |
| 6 | ALXOALX Oncology Holdings Inc | 4,220,048 | $34.1B | 3.43% | |
| 7 | TARSTarsus Pharmaceuticals Inc | 2,312,368 | $33.8B | 3.39% | |
| 8 | —Impel NeuroPharma Inc | 2,884,789 | $26.9B | 2.70% | |
| 9 | GONGeron Corp | 15,238,095 | $23.6B | 2.37% | |
| 10 | VTYXVentyx Biosciences Inc | 1,921,726 | $23.5B | 2.36% | |
| 11 | AMRSEURAmyris, Inc | 11,642,195 | $21.5B | 2.16% | |
| 12 | COGTCogent Biosciences Inc | 1,920,941 | $17.3B | 1.74% | |
| 13 | 290AChinook Therapeutics Inc | 872,151 | $15.3B | 1.53% | |
| 14 | KALVKalVista Pharmaceuticals Inc. | 1,533,559 | $15.1B | 1.52% | |
| 15 | TCE2Celldex Therapeutics Inc | 558,636 | $15.1B | 1.51% | |
| 16 | VRDNViridian Therapeutics Inc | 1,300,000 | $15.0B | 1.51% | |
| 17 | IOBTIO Biotech Inc | 3,015,545 | $14.1B | 1.41% | |
| 18 | —Genetron Holdings Ltd | 8,124,174 | $13.8B | 1.39% | |
| 19 | ASNDAscendis Pharma A/S | 146,025 | $13.6B | 1.36% | |
| 20 | LEGNLegend Biotech Corp Sponsored | 244,375 | $13.4B | 1.35% | |
| 21 | RLMDRelmada Therapeutics Inc | 705,882 | $13.4B | 1.35% | |
| 22 | ACRSAclaris Therapeutics, Inc. | 898,631 | $12.5B | 1.26% | |
| 23 | VRNAVerona Pharma PLC | 2,749,918 | $11.5B | 1.16% | |
| 24 | MRUSMerus NV | 442,000 | $10.0B | 1.00% | |
| 25 | ZLABZai Lab Ltd ADR | 271,528 | $9.4B | 0.95% | |
| 26 | BLUBellus Health Inc | 1,017,152 | $9.4B | 0.94% | |
| 27 | VERAVera Therapeutics Inc | 666,666 | $9.1B | 0.91% | |
| 28 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $7.9B | 0.79% | |
| 29 | IOVAIovance Biotherapeutics Inc | 655,057 | $7.2B | 0.73% | |
| 30 | AVDLAvadel Pharmaceuticals PLC | 2,937,093 | $7.2B | 0.72% | |
| 31 | OLMAOlema Pharmaceuticals Inc | 1,689,515 | $6.9B | 0.69% | |
| 32 | DSGNDesign Therapeutics | 476,589 | $6.7B | 0.67% | |
| 33 | TERNTerns Pharmaceuticals Inc | 2,675,133 | $6.6B | 0.67% | |
| 34 | WHWKAadi Bioscience Inc | 509,572 | $6.3B | 0.63% | |
| 35 | CMPXCompass Therapeutics Inc | 2,000,000 | $5.3B | 0.53% | |
| 36 | GRCLGracell Biotechnologies Inc | 961,359 | $5.3B | 0.53% | |
| 37 | —Minerva Surgical Inc | 2,215,667 | $5.2B | 0.52% | |
| 38 | —Satsuma Pharmaceuticals Inc | 1,232,394 | $5.1B | 0.51% | |
| 39 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $4.8B | 0.49% | |
| 40 | ALGSAligos Therapeutics Inc | 3,547,030 | $4.3B | 0.43% | |
| 41 | CDXSCodexis, Inc | 388,144 | $4.1B | 0.41% | |
| 42 | DYNDyne Therapeutics Inc | 577,642 | $4.0B | 0.40% | |
| 43 | SERASera Prognostics Inc | 1,856,011 | $3.0B | 0.31% | |
| 44 | RZLTRezolute Inc | 489,473 | $1.6B | 0.16% | |
| 45 | —Zymeworks Inc | 286,064 | $1.5B | 0.15% | |
| 46 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $1.4B | 0.14% | |
| 47 | FIXXEURHomology Medicines, Inc. | 370,068 | $729.0M | 0.07% | |
| 48 | DTILPrecision Biosciences Inc | 140,255 | $224.0M | 0.02% | |
| 49 | —Metacrine Inc | 146,426 | $73.0M | 0.01% |